TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06269965

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Regeneten® adding
Description: Arthroscopic shoulder repair, in double row, with complete coverage of the foot print and addition of Regeneten®
Study: NCT04718272

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thoracic drainage management
Description: After uniportal VATS pulmonary lobectomy, the traditional silicone tube which placed through the surgical incision was removed in the operating room in the experimental group.
Study: NCT04365829

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality headset Occulus GO
Description: Use of a virtual reality headset for one week at a frequency of 3 days per week (D1, D3 and D5). During each session (1 hour), the subject will visualize a scene of natural virtual environment (a garden, animals in the wild, a grand Canyon) lasting 7 min using an virtual reality headset Occulus GO.
Study: NCT05649423

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: POSTURAL DRAINAGE WITH PERCUSSION
Description: Each position should be held for a minimum of five minutes. In each position, your chest should be lower than your hips to allow mucus to drain. On your back: Patient's chest should be lower than his hips, which you can achieve by lying on a slanted surface up about 18 to 20 inches. On your sides: With pillows under your hips, lie on one side. To clear congestion from the right and left lobes. On your stomach: Drape patient's body over a stack of pillows, this is best in clearance of mucus from the lower back area of the lungs.~Percussion The equipment required here is cupped hands of caregiver to deliver the force required to drain the thick secretions. Patient should be in a comfortable position to enhance the effect. This loosens the thick, sticky secretions from the walls of the lung allowing them to into the larger airways, The sound heard must be hollow. The force applied must be equal.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Postural drainage
Description: * Each position should be held for a minimum of five minutes.~* In each position, your chest should be lower than your hips to allow mucus to drain On your back: Patient's chest should be lower than your hips, which you can achieve by lying on a slanted surface or propping patient's hips up about 18 to 20 inches~* This position is best for draining the bottom front parts of your lungs. On your sides: With pillows under your hips, lie on one side so that your chest is lower than your hips. To clear congestion from the bottom part of the right lung, lie on your left side. To clear congestion from the bottom part of your left lung, lie on your right side.~On your stomach: Drape patient's body over a stack of pillows or other object, and rest his arms by his head, with his chest lower than his hips. This position is best for clearing mucus in the lower back area of the lungs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postural drainage
Description: * Each position should be held for a minimum of five minutes.~* In each position, your chest should be lower than your hips to allow mucus to drain On your back: Patient's chest should be lower than your hips, which you can achieve by lying on a slanted surface or propping patient's hips up about 18 to 20 inches~* This position is best for draining the bottom front parts of your lungs. On your sides: With pillows under your hips, lie on one side so that your chest is lower than your hips. To clear congestion from the bottom part of the right lung, lie on your left side. To clear congestion from the bottom part of your left lung, lie on your right side.~On your stomach: Drape patient's body over a stack of pillows or other object, and rest his arms by his head, with his chest lower than his hips. This position is best for clearing mucus in the lower back area of the lungs.
Study: NCT06432010

Intervention type: OTHER
Group type: OTHER
Intervention: Group nutrition and physical activity coaching
Description: Group nutrition and physical activity coaching consists of an initial health check-up, followed by nutrition and physical activity coaching sessions over 7 weeks, 2 telephone follow-ups at 3 and 6 months and finally a final health check-up, 12 months after the end of the group nutrition and physical activity coaching sessions.

Intervention type: OTHER
Group type: OTHER
Intervention: Group cognition coaching
Description: Group cognition coaching consists of an initial health check-up, followed by cognition coaching sessions over 7 weeks, 2 telephone follow-ups at 3 and 6 months and finally a final health check-up, 12 months after the end of the cognition coaching sessions.
Study: NCT05394831

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JIN-A02
Description: PO, QD
Study: NCT05990608

Intervention type: OTHER
Intervention: Peabody Developmental Motor Scales-2, PDMS
Description: The Peabody Developmental Engine Scales-2, PDMS, is a standardized norm-referenced test used to determine the motor skill level of children aged 0 to 6, identify delays in engine development, and determine individual needs and challenges. The 2 scalar, which allows children to evaluate rough and thin motor skills, consists of 6 sub-tests and 249 articles. The rough motor scale contains 4 sub-tests and 151 items, including reflex, equilibrium, locomotion and object manipulation. The slim motor scale consists of 2 sub-tests and 98 items, including cognition and visual-motor integration. Using the age-appropriate normal value ranges in the test manual to determine developmental stress risk and level, the coarse motor skills, slim motor skills, and general motor development are categorized as very low, low, below average, above average, high, very high.

Intervention type: OTHER
Intervention: Peabody Developmental Motor Scales-2, PDMS
Description: The Peabody Developmental Engine Scales-2, PDMS, is a standardized norm-referenced test used to determine the motor skill level of children aged 0 to 6, identify delays in engine development, and determine individual needs and challenges. The 2 scalar, which allows children to evaluate rough and thin motor skills, consists of 6 sub-tests and 249 articles. The rough motor scale contains 4 sub-tests and 151 items, including reflex, equilibrium, locomotion and object manipulation. The slim motor scale consists of 2 sub-tests and 98 items, including cognition and visual-motor integration. Using the age-appropriate normal value ranges in the test manual to determine developmental stress risk and level, the coarse motor skills, slim motor skills, and general motor development are categorized as very low, low, below average, above average, high, very high.
Study: NCT05276869

Intervention type: OTHER
Intervention: WeeFIM instrument
Description: In a formative setting, the WeeFIM tool examines functional independence in kids aged 6 months to 7 years old. It can also be used with children over the age of 7 who show functional ability. The instrument may be controlled by observational data or a meeting, and it takes 15 to 20 minutes to create \[10\].

Intervention type: OTHER
Intervention: WeeFIM instrument
Description: In a formative setting, the WeeFIM tool examines functional independence in kids aged 6 months to 7 years old. It can also be used with children over the age of 7 who show functional ability. The instrument may be controlled by observational data or a meeting, and it takes 15 to 20 minutes to create \[10\].
Study: NCT06510699

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: genotype-directed dosing with dosing software based on therapeutic drug monitoring
Description: Genotype-directed dosing with dosing software based on therapeutic drug monitoring
Study: NCT06335511

Intervention type: PROCEDURE
Intervention: microsurgical decompression
Description: decompression of neurological structures
Study: NCT06359223

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: coffee consumption
Description: After cesarean section, patients will be allowed to drink coffee.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: Patients will undergo a routine surgical procedure.
Study: NCT05482217

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, problem solving and rehearsal (cognitive behavioural intervention)
Description: The highlights of the intervention.~Session 1: Rapport building and knowledge of HIV~Session 2: Identifying and Dealing with barriers to good adherence~Session 3: Identifying and dealing with problems in relation to depression and adherence:~Session 4: Identifying and dealing with negative cognitions, handling privacy, accessing social Support, and adjusting to HIV and antiretroviral treatment~Session 5: Rehearsal of practical tips on adherence, handling slips, and strategies to improve quality of life.~All sessions involved brief periods of relaxation, homework, and a homework review. The last session was concluded with the assessment of satisfaction with the program. The programs were conducted for 60 minutes weekly for five weeks.~They were delivered by a trained lay counselor and supervised by the principal investigator for five weeks.
Study: NCT02725554

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: StimRelieve Halo System
Description: The StimRelieve Halo System is intended as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach for chronic migraine as defined by the Third edition of the International Classification of headache disorders (ICDH-3). The system provides treatment by delivering small controlled electrical pulses to the occipital and supraorbital nerves, as it has been shown that for chronic migraine headaches the response to combined systems appears to be substantially better than occipital nerves stimulation alone.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: StimRelieve Halo System
Description: The StimRelieve Halo System is intended as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach for chronic migraine as defined by the Third edition of the International Classification of headache disorders (ICDH-3). The system provides treatment by delivering small controlled electrical pulses to the occipital and supraorbital nerves, as it has been shown that for chronic migraine headaches the response to combined systems appears to be substantially better than occipital nerves stimulation alone.
Study: NCT05474014

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: superior trunk block
Description: Local anesthetic injection will be applied to the superior trunk of the brachial plexus accompanied by ultrasonography.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravenous patient-controlled analgesia
Description: Analgesics will be given using a patient-controlled analgesia device.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravenous patient-controlled analgesia
Description: Analgesics will be given using a patient-controlled analgesia device.
Study: NCT05839444

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: BioPB-01
Description: 2 sachets/day, one to be taken orally with (4±1 mins prior) at breakfast and one (4±1 mins prior) at dinner

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 sachets/day, one to be taken orally with (4±1 mins prior) at breakfast and one (4±1 mins prior) at dinner
Study: NCT05937412

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol sterilization
Description: Sterilizing skin using alcohol

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Honey sterilization
Description: Sterilizing skin using honey
Study: NCT05628610

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200mg d1, Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200mg d1, Q3W

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Radiotherapy dose: 5,000 c G y / 30f

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel: 150mg / m2 ,d1, q3w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum: cisplatin, carboplatin, naidaplatin and other platinum drugs
Description: cisplatin, carboplatin, naidaplatin and other platinum drugs
Study: NCT06288451

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral calcitriol with cinacalcet rescue
Description: Participants will receive in-center oral calcitriol at a fixed dose of 0.5 mcg three times weekly at their dialysis treatment sessions regardless of their parathyroid hormone (PTH) concentrations over the 12-month trial period. Only if their serum PTH exceeds 800 pg/mL over 2 consecutive measurements will they be started on cinacalcet at 30 mg/d in order to protect against severe unremitting hyperparathyroidism.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV activated vitamin D
Description: Participants will continue to receive intravenously-administered activated vitamin D per the Northwest Kidney Center treatment protocol, dose-titrated to monthly to quarterly parathyroid hormone concentrations.
Study: NCT06520618

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qing Re He Ji
Description: Oral administration of Qing Re He Ji

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Shuanghuanglian Oral Liquid
Description: Oral administration of Shuanghuanglian Oral Liquid
Study: NCT05553821

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold sand bag
Description: A sand bag weighing 3.5-4 kg is applied to the CAG area of patients.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A sand bag
Description: A sand bag
Study: NCT06206304

Intervention type: OTHER
Intervention: Root canal therapy
Description: Traditional root canal therapy was performed with rubber-dam isolation.

Intervention type: OTHER
Intervention: Root canal therapy
Description: Traditional root canal therapy was performed with rubber-dam isolation.
Study: NCT04885517

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine
Study: NCT06335511

Intervention type: PROCEDURE
Intervention: decompression and instrumented fusion
Description: decompression of neurological structures and spine stabilization
Study: NCT04885517

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esophageal catheter
Description: Patients are equipped with an esophageal catheter: positioning is performed after accurate nasopharyngeal anesthesia with lidocaine
Study: NCT06574321

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teen Talk High School Refresher (TTHSR)
Description: TTHSR is designed to equip 11th and 12th grade students with the knowledge and skills necessary to make informed sexual health decisions as they transition from high school into adulthood, in order to prevent behavioral risk factors that contribute to unintended pregnancy and sexually transmitted infections.~As a result of the California Healthy Youth Act, which mandates sexual health education (SHE) in public schools, most students this age will have received prior SHE. TTHSR is a 5-hour booster intervention, delivered in five 1-hour sessions during late high school, intended to enhance the effectiveness of previous SHE.
Study: NCT05339542

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: platelet rich plasma
Description: derived from patient own blood

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MethylPREDNISolone 40 MG
Description: active comparative intervention
Study: NCT04681807

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotion Recognition Training
Description: Participants will undergo 2 fMRI scans, one before and one after the training sessions. There will be 4 visits consisting of an emotion recognition training exercise on iPad, lasting for a period of \~1 hour each. (More details about each condition will be added after study completion to protect the blinding of participants) .

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control Training
Description: Participants will undergo 2 fMRI scans, one before and one after the training sessions. There will be 4 visits consisting of a control training exercise on iPad, lasting for a period of \~1 hour each. (More details about each condition will be added after study completion to protect the blinding of participants) .
Study: NCT05205824

Intervention type: OTHER
Group type: OTHER
Intervention: algorithm validation
Description: stroke subjects are measured to validate algorithms previously developed after including healthy subjects
Study: NCT05932407

Intervention type: DRUG
Intervention: Vortioxetine Tablet
Description: Vortioxetine Tablet

Intervention type: DRUG
Intervention: SSRI
Description: SSRI: Selective Serotonin Reuptake Inhibitor
Study: NCT04977388

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Droxidopa
Description: Subjects will self-administer capsules of Droxidopa by mouth twice daily for six weeks.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will self-administer capsules of placebo by mouth twice daily for six weeks.
Study: NCT06538571

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Near infrared spectroscopy
Description: Noninvasive monitor for venous saturation
Study: NCT06519422

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid 500 MG
Description: Tablets

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Matched placebo
Description: Matched placebo tablets (inactive ingredients only, including microcrystalline cellulose, magnesium stearate BP and lactose)
Study: NCT05914467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teicoplanin
Description: Dose will be adjusted in the study arm using MIPD guided TDM- dosing
Study: NCT04637282

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLX-200
Description: 15 mg/mL oral solution of experimental drug

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Taste and color-matched drug-free solution
Study: NCT05939713

Intervention type: DEVICE
Intervention: Cera™ VSD occluder implantation
Description: To collect data from patients who have implanted with the device before 2022.
Study: NCT05286580

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Morbidity and mortality conference toolkit
Description: * Standardized slide deck~* Code of conduct~* Conference planning checklist~* Case documentation form
Study: NCT06602037

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [89Zr]Zr-DFO-SHR1920
Description: Enrolled pancreatic cancer patients will receive a single dose (1-3mCi) of \[89Zr\]Zr-DFO-SHR1920 (total 1-2mg antibody mass). Multiple immunoPET/CT imaging sessions will be performed on day 0, day 1(24 h), day 3 (72 h), day 5 (120 h) or day 7 (168 h).

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [18F]F-RESCA-3A12
Description: Enrolled pancreatic cancer patients will receive 0.05-0.1mCi/kg of \[18F\]F-RESCA-3A12. ImmunoPET/CT imaging will be acquired 1h after \[18F\]F-RESCA-3A12 injection.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-NOTA-3A12
Description: Enrolled pancreatic cancer patients will receive 0.05-0.1mCi/kg of \[68Ga\]Ga-NOTA-3A12. ImmunoPET/CT imaging will be acquired 1h after \[68Ga\]Ga-NOTA-3A12 injection.
Study: NCT06689592

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Intermittent theta burst stimulation
Study: NCT06626568

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound betamethasone Injection(Gluteal muscle injection)
Description: gluteal injection of 1 ml of Compound betamethasone and 4 ml of normal saline at week 0,2,4

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Compound betamethasone Injection(Subacromial Ultrasound Guided injection)
Description: ultrasound-guided subacromial injection of 1 ml of Compound betamethasone and 4 ml of normal saline at week 0,2,4.
Study: NCT05953194

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to counter-marketing messages
Description: Counter-marketing messages about sugary drinks that incorporate principles of effective counter-marketing campaigns, including describing industry manipulation of consumers, appealing to emotions (especially anger), describing health consequences, and criticizing the industry for demographic targeting. Messages include text adapted from prior counter-marketing campaigns. Participants will view a total of 4 messages developed for this arm.